Abstract

The pharmaceutical industry is one of the most innovative sectors in the world. In 2014, the global drug sales market exceeded one trillion dollars for the first time. Innovative, patented drugs represent the largest part of pharmaceutical sales revenues. Nowadays partnerships, licensing and M&A are important parts of R&D strategies to use assets in the most efficient way and accelerate translation of biomedical innovations to bring novel products, services and solutions to the market for patients who need them.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call